Table 3.

Prevalence for hyperuricemia (serum uric acid > 7.0 mg/dL) and hypouricemia (serum uric acid ≤ 2.0 mg/dL) excluding chronic kidney disease (CKD-EPI < 60 mL/min/1.73 m²) in the Korean population

Classification	Total population in cohort	No. of classified participants in cohort	Prevalence per 1000 persons (95% CI)
Hyperuricemia
Overall	169,408	7,744	45.71 (44.73–46.72)
Male	57,375	7,115	124.01 (121.34–126.73)
Female	112,033	629	5.61 (5.19–6.07)
Age, yr
40–49	63,417	2,816	44.40 (42.83–46.04)
50–59	65,800	2,884	43.83 (42.29–45.42)
60–69	37,081	1,876	50.59 (48.41–52.87)
70–79	3,110	168	54.02 (46.61–62.53)
Hypouricemia
Overall	169,408	707	4.17 (3.88–4.49)
Male	57,375	61	1.06 (0.83–1.37)
Female	112,033	646	5.77 (5.34–6.23)
Age, yr
40–49	63,417	350	5.52 (4.97–6.13)
50–59	65,800	223	3.39 (2.97–3.86)
60–69	37,081	120	3.24 (2.71–3.87)
70–79	3,110	14	4.50 (2.68–7.54)

CKD-EPI, chronic kidney disease epidemiology collaboration; CI, confidence interval.